Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)
J. Steen Jensen, Massar Omar, Caroline Kistorp, Christian Tuxen, Ida Gustafsson, Lars Køber, Finn Gustafsson, Jens Faber, Julie Lyng Forman, Jacob Eifer Møller, Morten Schou
Topics & Concepts
MedicineEmpagliflozinHeart failurePlaceboRandomized controlled trialDouble blindPlacebo-controlled studyCardiologyInternal medicineDiabetes mellitusEndocrinologyType 2 diabetesAlternative medicinePathologyDiabetes Treatment and ManagementPancreatic function and diabetesCardiovascular Function and Risk Factors